Adenosine
NDC 67457-856, adenosine, injection, solution, from Mylan Institutional LLC.
- Product NDC
- 67457-856
- Status
- Listed
- Labeler
- Mylan Institutional LLC
- Dosage form
- INJECTION, SOLUTION
- Route
- INTRAVENOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA090212
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/67457-856 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- ADENOSINE3 mg/mL
Pharmacologic classes
Adenosine Receptor Agonist [EPC]; Adenosine Receptor Agonists [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 67457-856-20 | 67457085620 | 1 VIAL in 1 CARTON (67457-856-20) / 20 mL in 1 VIAL |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/23e5c868-944f-4cc8-887f-9a2dc811af92Medicare Part B payment limits (ASP)
GET /v1/drugs/asp?ndc=67457-856
Use it
Look up 67457-856 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/67457-856 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 67457-856. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.